Key facts
- It has raised $3.1M; the latest was Later Stage VC in Jan 2027.
- Notable investors include Plug and Play Tech Center, SOSV, EIT Food, Innovation Authority, AgFunder — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Exosomm
- ·The full record, as it builds
Funding rounds
No funding rounds for Exosomm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Exosomm
Operator of nutraceutical ingredients intended to enhance cellular communication and support health through bioactive compounds. The company's platform offers milk-derived exosome-based formulations processed into shelf-stable powders for improved bioavailability and stability, enabling nutraceutical manufacturers and health-focused consumers to support digestive health and manage inflammation.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Katzrin, Israel
- Founded
- 2021
- Employees
- 4
- Website
- exosomm.com/
- Ownership
- Privately Held (backing)
Exosomm doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Exosomm shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Exosomm in its N-PORT filings yet. We sweep new filings monthly.